Literature DB >> 28057415

Comprehensive Genomic Analysis of Metastatic Mucinous Urethral Adenocarcinoma Guides Precision Oncology Treatment: Targetable EGFR Amplification Leading to Successful Treatment With Erlotinib.

Alan H Bryce1, Mitesh J Borad2, Jan B Egan3, Rachel M Condjella4, Winnie S Liang5, Rafael Fonseca2, Ann E McCullough6, Katherine S Hunt7, Nicole R Ritacca4, Michael T Barrett8, Maitray D Patel9, Scott W Young9, Alvin C Silva9, Thai H Ho2, Thorvardur R Halfdanarson2, Melissa L Stanton6, John Cheville10, Scott Swanson11, Daniel E Schneider11, Robert R McWilliams12, Angela Baker5, Jessica Aldrich5, Ahmet Kurdoglu5, Tyler Izatt5, Alexis Christoforides5, Irene Cherni5, Sara Nasser5, Rebecca Reiman5, Lori Cuyugan5, Jacquelyn McDonald5, Jonathan Adkins5, Stephen D Mastrian5, Daniel D Von Hoff5, David W Craig5, A Keith Stewart2, John D Carpten5.   

Abstract

Entities:  

Keywords:  EGFR; Exome; Genome; Transcriptome; Urethral adenocarcinoma

Mesh:

Substances:

Year:  2016        PMID: 28057415     DOI: 10.1016/j.clgc.2016.11.001

Source DB:  PubMed          Journal:  Clin Genitourin Cancer        ISSN: 1558-7673            Impact factor:   2.872


× No keyword cloud information.
  1 in total

1.  Systemic treatment for coexisting mucinous urethral adenocarcinoma and prostate adenocarcinoma.

Authors:  Kunihisa Nezu; Teppei Okubo; Manabu Shiraiwa; Yoshihiro Nozawa; Atsushi Kyan
Journal:  IJU Case Rep       Date:  2020-08-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.